Loading…
Cyclooxygenase-2 Expression Is Related to Prostaglandin Biosynthesis and Angiogenesis in Human Gastric Cancer
Although recent studies have demonstrated that cyclooxygenase (COX)-2 is overexpressed in various cancers including gastric cancer, the mechanisms underlying the contribution of COX-2 to tumorigenesis and tumor promotion still remain unclear. To determine the role of COX-2, we investigated the COX-2...
Saved in:
Published in: | Clinical cancer research 2000-01, Vol.6 (1), p.135-138 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Although recent
studies have demonstrated that cyclooxygenase (COX)-2 is overexpressed
in various cancers including gastric cancer, the mechanisms underlying
the contribution of COX-2 to tumorigenesis and tumor promotion still
remain unclear. To determine the role of COX-2, we investigated the
COX-2 expression, the prostaglandin (PG) levels, and the microvessel
density in 42 patients with primary gastric adenocarcinoma. COX-2
protein was overexpressed in 31 (74%) of 42 gastric cancers based on
an immunoblot analysis. The intensity of COX-2 expression was found to
significantly correlate with lymph node involvement. The COX-2
overexpressed cases showed significantly elevated levels of
prostaglandin E 2 (PGE 2 ) in cancer
tissues in comparison with the normal gastric mucosa by an immunoassay
(201 ± 90 versus 161 ± 57 ng/mg protein;
P < 0.05). However, the COX-2 overexpression was
not related to the levels of thromboxane B 2 and
6-keto-prostaglandin F 1α . The density of
microvessel immunostained with CD34 was significantly higher in
patients demonstrating COX-2 overexpression than in those without such
expression (63 ± 21 versus 45 ± 17/200 ×; P < 0.01). Our data thus suggested COX-2
overexpression to be associated with increased PGE 2
biosynthesis and angiogenesis in gastric cancer, which indicates that
COX-2 may play a role in the development of gastric cancer. |
---|---|
ISSN: | 1078-0432 1557-3265 |